Buchler GmbH
  • Products
    • Active Pharmaceutical Ingredients
    • Asymmetric Synthesis
      • Chiral Building Blocks
      • Chiral Phase Transfer Catalysts (PTCs)
      • Chiral Screening Kit
      • Enantioselective Organocatalysts
      • Racemic Resolution
    • Food Ingredients
    • Product Overview
  • Chiral Catalyst Search (NEW)
  • Contact
  • About
    • Certificates
    • Company Policy
    • Former Buchler Company Managers
    • Galleries
      • Gallery current production and storage
      • Gallery Laboratory
      • Gallery Historical Production
    • History of Buchler
  • Career
Select Page

Trifluoromethylthiolation, substituted 2,4-dihydro-3H-pyrazol-3-one, 2-((trifluoromethyl)thio)benzo[d]isothiazol-3(2H)-one 1,1-dioxide, (R)-4-(3,5-dimethoxybenzyl)-2,5-diphenyl-4-((trifluoromethyl)thio)-2,4-dihydro-3H-pyrazol-3-one, (9S)-9-hydroxy-6′-methoxy-1-[2-oxo-2-[(triphenylmethyl)amino]ethyl]-cinchonanium bromide, Quinidine Derivative

by werner@buchler-gmbh.com | Jan 24, 2025

Michael Addition, substituted (E)-3-(prop-1-en-1-yl)benzo[d]isothiazole 1,1-dioxide, malononitrile, (9S)-substituted 7-amino–9H-benzo[4,5]isothiazolo[2,3-a]pyridine-8-carbonitrile 5,5-dioxide, Quinidine Base

by werner@buchler-gmbh.com | May 11, 2023

Michael Addition, methyl 2-oxocyclopentane-1-carboxylate, (E)-(2-nitrovinyl)benzene, methyl (R)-1-((S)-2-nitro-1-phenylethyl)-2-oxocyclopentane-1-carboxylate, 3,4-Bis[[(8α,9S)-6′-methoxycinchonan-9-yl]amino]- 3-cyclobutene-1,2-dione, Quinine Derivative

by Anna-Lena Hartmann | Jul 20, 2022

Glossary

Impressum / Legal Notice

Code of Conduct

Hinweisgebersystem / Whistleblowing System

Allgemeine Geschäfts-bedingungen / General Terms and Conditions

Datenschutzhinweise / Data Protection Information

Contact

My Account
  • Follow
  • Follow

All Rights Reserved by Buchler GmbH